AU2003266622A8 - Medicinal composition for inhibiting increase in blood gastrin concentration - Google Patents

Medicinal composition for inhibiting increase in blood gastrin concentration

Info

Publication number
AU2003266622A8
AU2003266622A8 AU2003266622A AU2003266622A AU2003266622A8 AU 2003266622 A8 AU2003266622 A8 AU 2003266622A8 AU 2003266622 A AU2003266622 A AU 2003266622A AU 2003266622 A AU2003266622 A AU 2003266622A AU 2003266622 A8 AU2003266622 A8 AU 2003266622A8
Authority
AU
Australia
Prior art keywords
medicinal composition
inhibiting increase
gastrin concentration
blood gastrin
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003266622A
Other versions
AU2003266622A1 (en
Inventor
Keiichi Ito
Atsuyuki Tomizawa
Masahiko Hagihara
Nobuhiko Shibakawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Ube Corp
Original Assignee
Sankyo Co Ltd
Ube Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd, Ube Industries Ltd filed Critical Sankyo Co Ltd
Publication of AU2003266622A1 publication Critical patent/AU2003266622A1/en
Publication of AU2003266622A8 publication Critical patent/AU2003266622A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003266622A 2002-09-25 2003-09-25 Medicinal composition for inhibiting increase in blood gastrin concentration Abandoned AU2003266622A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002278551 2002-09-25
JP2002-278551 2002-09-25
PCT/JP2003/012263 WO2004029058A1 (en) 2002-09-25 2003-09-25 Medicinal composition for inhibiting increase in blood gastrin concentration

Publications (2)

Publication Number Publication Date
AU2003266622A1 AU2003266622A1 (en) 2004-04-19
AU2003266622A8 true AU2003266622A8 (en) 2004-04-19

Family

ID=32040430

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003266622A Abandoned AU2003266622A1 (en) 2002-09-25 2003-09-25 Medicinal composition for inhibiting increase in blood gastrin concentration

Country Status (3)

Country Link
AU (1) AU2003266622A1 (en)
TW (1) TW200420293A (en)
WO (1) WO2004029058A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991017164A1 (en) * 1990-04-27 1991-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel pyridazines
CA2095351C (en) * 1990-11-26 1998-12-15 Mark L. Kacher Shaped solid made with a rigid, interlocking mesh of neutralized carboxylic acid
DK0609328T3 (en) * 1991-10-25 1999-10-25 Byk Gulden Lomberg Chem Fab Pyrrolo-pyridazines with gastrointestinal protective effect
DE69529056T2 (en) * 1994-01-19 2003-11-13 Sankyo Co Pyrrolopyridazine DERIVATIVES
SE9704404D0 (en) * 1997-11-28 1997-11-28 Astra Ab New compounds
TWI287014B (en) * 1999-06-15 2007-09-21 Sankyo Co Optically active pyrrolopyridazine compound
EP1254907B1 (en) * 2000-02-10 2007-05-09 Sankyo Company, Limited Pyrrolopyridazine compound
JP2002068992A (en) * 2000-08-25 2002-03-08 Ito En Ltd Eradicating agent for helicobacter pylori, and food, beverage or food additive having this eradicating effect
JP3387066B2 (en) * 2000-12-14 2003-03-17 三共株式会社 Anti-ulcer agent containing pyrrolopyridazine compound
JP2003119140A (en) * 2001-08-08 2003-04-23 Sankyo Co Ltd Pharmaceutical agent containing pyrrolopyridazine compound

Also Published As

Publication number Publication date
TW200420293A (en) 2004-10-16
WO2004029058A1 (en) 2004-04-08
AU2003266622A1 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
GB0206033D0 (en) Compounds useful in therapy
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
AU2003291103A8 (en) Pharmaceutical composition
GB2394894B (en) New use for pharmaceutical composition
IL164547A0 (en) Pharmaceutical composition
IL171902A0 (en) Compositions comprising gastrin compounds and their use in diabetes
AU2003250372A8 (en) Pharmaceutical composition
HK1093896A1 (en) Medicinal composition
EP1600445A4 (en) Medicinal composition
EP1670755A4 (en) Pyrovalerone analogs and therapeutic uses thereof
HK1095737A1 (en) Medicinal composition in solution form
HK1081451A1 (en) Medicinal composition
HK1065477A1 (en) Pharmaceutical composition
AU2003215767A8 (en) Devices for use in medicine
AU2003266622A8 (en) Medicinal composition for inhibiting increase in blood gastrin concentration
HK1062274A1 (en) Medicinal composition
GB0022922D0 (en) Compounds for use in medicine
GB0312844D0 (en) Use of compounds in medicine
EP1547593A4 (en) Medicinal composition
GB0217703D0 (en) Pharmaceutical composition
GB0209874D0 (en) Devices for use in medicine
GB0217335D0 (en) Improvements in medical apparatus
GB0203803D0 (en) Improvements in syringes
GB0225549D0 (en) Improvements in medical devices

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase